Major Drug Interaction

Can You Take Paracetamol with METHOCARBAMOL?

A plain-English look at the major interaction between Paracetamol (PHARMACY CARE PARACETAMOL) and METHOCARBAMOL (Methocarbamol) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Major severity AllMeds interaction database Updated April 2026

Taking Paracetamol (PHARMACY CARE PARACETAMOL) with METHOCARBAMOL (Methocarbamol) is a major drug interaction that should be avoided. Excessive sedation, respiratory depression, falls. Additive CNS depression. Both classes cause sedation and respiratory depression through complementary pathways.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Major
  • Risk: Excessive sedation, respiratory depression, falls.
  • Mechanism: Additive CNS depression. Both classes cause sedation and respiratory depression through complementary pathways.
  • Paracetamol: S2 in Australia, low risk
  • METHOCARBAMOL: S4 in Australia, low risk
  • Claims action: Flag for immediate prescriber review. Document intervention in claim file.

Paracetamol vs METHOCARBAMOL at a Glance

Property Paracetamol METHOCARBAMOL
Brand names PHARMACY CARE PARACETAMOL, Wagner Health Paracetamol, Paracetamol Sandoz Pharma Methocarbamol
Drug class opioid muscle relaxant
Risk level low low
TGA Schedule (AU) S2 S4

Why Is This Combination Dangerous?

Additive CNS depression. Both classes cause sedation and respiratory depression through complementary pathways.

Clinical risk: Excessive sedation, respiratory depression, falls.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.

United Kingdom NICE / MHRA / FPM

UK clinical guidelines recommend caution with this combination. For personal injury claims, the prescribing rationale should be documented and reviewed against NICE and FPM guidance.

United States FDA / CDC / State WC

The CDC and FDA recommend monitoring concurrent CNS depressant use. State workers compensation formularies may restrict or require prior authorization for this combination.

What Claims Professionals Should Do

  1. Flag immediately as a high-risk prescribing pattern in the claim file
  2. Request urgent prescriber review with documented clinical justification for the combination
  3. Consider an independent medical examination if the prescriber cannot provide adequate justification
  4. Assess work capacity impact as the combination significantly increases sedation and impairment risk
  5. Document all interventions for audit trail and compliance purposes
  6. Check Reasonable and Necessary status for both medications against the compensable injury

Check this medication against your full medication list

Check all interactions for Paracetamol and METHOCARBAMOL across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.